INTECH Investment Management’s Disc Medicine IRON Stock Holding History

INTECH Investment Management’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$443K	Buy	6,054 +186	+3%	+$12.8K	﹤0.01%	1397
2026 Q1	$375K	Sell	5,868 -4,042	-41%	-$281K	﹤0.01%	1474
2025 Q4	$787K	Buy	9,910 +1,904	+24%	+$161K	0.01%	1259
2025 Q3	$529K	Sell	8,006 -4,216	-34%	-$251K	﹤0.01%	1549
2025 Q2	$647K	Buy	12,222 +1,274	+12%	+$59.8K	0.01%	1457
2025 Q1	$543K	Buy	10,948 +3,058	+39%	+$170K	0.01%	1566
2024 Q4	$500K	Buy	7,890 +3,243	+70%	+$188K	﹤0.01%	1563
2024 Q3	$228K	Buy	+4,647	New	+$218K	﹤0.01%	1661

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

INTECH Investment Management's IRON Position: Q2 2026 in Review

INTECH Investment Management increased its Disc Medicine (IRON) stake by 3.2% in Q2 2026, buying an estimated $12.8K and bringing the position to 6,054 shares worth $443K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

INTECH Investment Management first reported a position in IRON in Q3 2024 and has held it in 8 quarters since. The position peaked at $787K in Q4 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

INTECH Investment Management held 6,054 shares of Disc Medicine worth $443K as of Q2 2026.
INTECH Investment Management bought 186 Disc Medicine shares in Q2 2026, an estimated $12.8K.
Disc Medicine made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1397 holding.
INTECH Investment Management first reported a position in Disc Medicine in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Disc Medicine position peaked at $787K in Q4 2025.
215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.